What is GSK-1070916 used for?

GSK-1070916 is currently being researched for its potential to treat neoplasms, which are tumors or cancerous growths.

Is GSK-1070916 an approved drug?

No, GSK-1070916 is currently in the early stages of research and is not an approved medication.

What stage of testing is GSK-1070916 in?

GSK-1070916 is in Phase 1 of clinical development.

Are there known side effects for GSK-1070916?

There are no human side effects listed because the drug is still in the early research phase.

Can I buy GSK-1070916?

No, GSK-1070916 is a research compound and is not available for purchase or use by the public.

What kind of molecule is GSK-1070916?

GSK-1070916 is classified as a small molecule.

Gsk-1070916 | CAS 942918-07-2 | QTBWCSQGBMPECM

Loading compound...

Small molecule research compound

GSK-1070916 is a small molecule compound currently being studied in early-stage research. It is being investigated for its potential use in treating neoplasms (tumors or cancer), but it is not yet an approved medication for consumer use.

How it worksGSK-1070916 is a small molecule that shows activity against various biological targets related to cell growth and survival, though its specific mechanism of action in humans is still under investigation.

Used for

Neoplasms (cancerous growths)

Conditions

neoplasm

Class

Small moleculeSmall molecule research compound

How to take

This compound is in the early stages of clinical development (Phase 1) and is not available for prescription or over-the-counter use.

Talk to your doctor

Questions to ask

·Is GSK-1070916 being used in any clinical trials I might qualify for?
·What is the current research status of GSK-1070916 for neoplasm treatment?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)